Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: Potential role of moxifloxacin

Taban, 2005, Acute endophthalmitis following cataract surgery; a systematic review of the literature., Arch Ophthalmol, 123, 613, 10.1001/archopht.123.5.613 West, 2005, The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001., Ophthalmology, 112, 1388, 10.1016/j.ophtha.2005.02.028 Javitt, 1991, National outcomes of cataract extraction: endophthalmitis following inpatient surgery., Arch Ophthalmol, 109, 1085, 10.1001/archopht.1991.01080080045025 Aaberg, 1998, Nosocomial acute-onset postoperative endophthalmitis survey: a ten-year review of incidence and outcomes., Ophthalmology, 105, 1004, 10.1016/S0161-6420(98)96000-6 Schmitz, 1999, Endophthalmitis in cataract surgery; results of a German survey., Ophthalmology, 106, 1869, 10.1016/S0161-6420(99)90395-0 Khan, 2005, Incidence of presumed postoperative endophthalmitis in Dublin for a 5-year period (1997-2001)., J Cataract Refract Surg, 31, 1575, 10.1016/j.jcrs.2005.01.031 Nagaki, 2003, Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type., J Cataract Refract Surg, 29, 20, 10.1016/S0886-3350(02)01483-9 Montan, 2002, Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery., J Cataract Refract Surg, 28, 977, 10.1016/S0886-3350(01)01269-X Javitt, 1995, Geographic variation in utilization of cataract surgery., Med Care, 33, 90, 10.1097/00005650-199501000-00008 Leaming, 2003, Practice styles and preferences of ASCRS members2002 survey., J Cataract Refract Surg, 29, 1412, 10.1016/S0886-3350(03)00405-X Bratzler, 2004, Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project; the Surgical Infection Prevention Guidelines Writers Workgroup. Clin Infect Dis. 2004;38:1706-1715., erratum, 39, 441 Seal, 2006, ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group., J Cataract Refract Surg, 32, 396, 10.1016/j.jcrs.2006.02.014 Barry, 2006, ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group., J Cataract Refract Surg, 32, 407, 10.1016/j.jcrs.2006.02.021 2007, Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors., J Cataract Refract Surg, 33, 978, 10.1016/j.jcrs.2007.02.032 Montan, 2002, Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery., J Cataract Refract Surg, 28, 982, 10.1016/S0886-3350(01)01270-6 Benz, 2004, Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases., Am J Ophthalmol, 137, 38, 10.1016/S0002-9394(03)00896-1 Recchia, 2005, Changing trends in the microbiologic aspects of postcataract endophthalmitis., Arch Ophthalmol, 123, 341, 10.1001/archopht.123.3.341 von Eiff, 2005, Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes., Antimicrob Agents Chemother, 49, 4372, 10.1128/AAC.49.10.4372-4374.2005 Noviello, 2003, Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens., J Antimicrob Chemother, 52, 869, 10.1093/jac/dkg429 Kazakova, 2005, A clone of methicillin-resistant Staphylococcus aureus among professional football players., N Engl J Med, 352, 468, 10.1056/NEJMoa042859 Stratton, 1987, Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies., Antimicrob Agents Chemother, 31, 1210, 10.1128/AAC.31.8.1210 Gupta, 2005, Macular thickness after cataract surgery with intracameral cefuroxime., J Cataract Refract Surg, 31, 1163, 10.1016/j.jcrs.2004.10.074 Koul, 1990, Intraocular levels of cefuroxime in uninflamed rabbit eyes., Acta Ophthalmol (Copenh), 68, 455, 10.1111/j.1755-3768.1990.tb01676.x Lin, 1992, A perspective on penicillin allergy., Arch Intern Med, 152, 930, 10.1001/archinte.1992.00400170020005 Anne, 1995, Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy., Ann Allergy Asthma Immunol, 74, 167 Pumphrey, 1999, Under-reporting of antibiotic anaphylaxis may put patients at risk., Lancet, 353, 1157, 10.1016/S0140-6736(99)00449-3 Berrocal, 2001, Subconjunctival cephalosporin anaphylaxis., Ophthalmic Surg Lasers, 32, 79, 10.3928/1542-8877-20010101-16 Villada, 2005, Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery., J Cataract Refract Surg, 31, 620, 10.1016/j.jcrs.2004.06.086 Mah, 2004, Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections., Curr Opin Ophthalmol, 15, 316, 10.1097/00055735-200408000-00007 Wright, 2000, Application of fluoroquinolone pharmacodynamics., J Antimicrob Chemother, 46, 669, 10.1093/jac/46.5.669 Kowalski, 2003, Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates., Am J Ophthalmol, 136, 500, 10.1016/S0002-9394(03)00294-0 Bauernfeind, 1997, Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin., J Antimicrob Chemother, 40, 639, 10.1093/jac/40.5.639 Mather, 2002, Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics., Am J Ophthalmol, 133, 463, 10.1016/S0002-9394(02)01334-X Yang, 2003, High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan., Antimicrob Agents Chemother, 47, 1958, 10.1128/AAC.47.6.1958-1962.2003 Doern, 2001, Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States., Clin Infect Dis, 33, S187, 10.1086/321847 Hwang, 2004, Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones., Surv Ophthalmol, 49, S79, 10.1016/j.survophthal.2004.01.004 Mah, 2003, New antibiotics for bacterial infections., Ophthalmol Clin North Am, 16, 11, 10.1016/S0896-1549(02)00104-9 Schentag, 2001, What have we learned from pharmacokinetic and pharmacodynamic theories?, Clin Infect Dis, 32, S39, 10.1086/319375 Katz, 2005, Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor., Cornea, 24, 955, 10.1097/01.ico.0000157423.78275.a2 Levine, 2004, Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing., J Cataract Refract Surg, 30, 2177, 10.1016/j.jcrs.2004.06.048 Solomon, 2005, Penetration of topically applied gatifloxacin 0.3, moxifloxacin 0.5, and ciprofloxacin 0.3 into the aqueous humor., Ophthalmology, 112, 466, 10.1016/j.ophtha.2004.09.029 McCulley, 2006, Fourth-generation fluoroquinolone penetration into the aqueous humor in humans., Ophthalmology, 113, 955, 10.1016/j.ophtha.2006.01.061 Robertson, 2005, Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans., Surv Ophthalmol, 50, S32, 10.1016/j.survophthal.2005.07.001 Hariprasad, 2005, Penetration pharmacokinetics of topically administered 0.5 moxifloxacin ophthalmic solution in human aqueous and vitreous., Arch Ophthalmol, 123, 39, 10.1001/archopht.123.1.39 Kim, 2005, Aqueous penetration and biological activity of moxifloxacin 0.5 ophthalmic solution and gatifloxacin 0.3 solution in cataract surgery patients., Ophthalmology, 112, 1992, 10.1016/j.ophtha.2005.06.017 Mather, 2004, The effect of cataract surgery on ocular levels of topical moxifloxacin., Am J Ophthalmol, 138, 554, 10.1016/j.ajo.2004.05.011 Dong, 1999, Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus., Antimicrob Agents Chemother, 43, 1756, 10.1128/AAC.43.7.1756 Price, 2002, Penetration of topically administered ofloxacin and trimethoprim into aqueous humor., J Ocular Pharmacol Ther, 18, 445, 10.1089/10807680260362722 Bucci, 2004, An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification., Am J Ophthalmol, 137, 308, 10.1016/j.ajo.2003.08.057 McGee, 2005, Safety of moxifloxacin as shown in animal and in vitro studies., Surv Ophthalmol, 50, S46, 10.1016/j.survophthal.2005.05.003 Donaldson, 2006, The effect of moxifloxacin on the normal human cornea., Curr Med Res Opin, 22, 2073, 10.1185/030079906X132668 Kovoor, 2004, Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy., Eye Contact Lens, 30, 90, 10.1097/01.ICL.00000117255.97190.98 Durrie, 2005, A comparison of therapeutic regimens containing moxifloxacin 0.5 ophthalmic solution and gatifloxacin 0.3 ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK., J Ocul Pharmacol Ther, 21, 236, 10.1089/jop.2005.21.236 Burka, 2005, The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy., Am J Ophthalmol, 140, 83, 10.1016/j.ajo.2005.02.037 Kowalski, 2004, Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model., Am J Ophthalmol, 138, 33, 10.1016/j.ajo.2004.02.051 Kowalski, 2005, Intracameral Vigamox (moxifloxacin 0.5) is non-toxic and effective in preventing endophthalmitis in a rabbit model., Am J Ophthalmol, 140, 497, 10.1016/j.ajo.2005.04.015 Gao, 2006, Intravitreal moxifloxacin: retinal safety study with electroretinographic and histopathology in animal models., Invest Ophthalmol Vis Sci, 47, 1606, 10.1167/iovs.05-0702 Espiritu, 2007, Safety of prophylactic intracameral moxifloxacin 0.5 ophthalmic solution in cataract surgery patients., J Cataract Refract Surg, 33, 63, 10.1016/j.jcrs.2006.09.019 Kleinmann, 2006, Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields., Cornea, 25, 209, 10.1097/01.ico.0000170689.75207.5e